23 related articles for article (PubMed ID: 10201829)
1. Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.
Prchalová E; Hin N; Thomas AG; Veeravalli V; Ng J; Alt J; Rais R; Rojas C; Li Z; Hihara H; Aoki M; Yoshizawa K; Nishioka T; Suzuki S; Kopajtic T; Chatrath S; Liu Q; Dong X; Slusher BS; Tsukamoto T
J Med Chem; 2019 Sep; 62(18):8631-8641. PubMed ID: 31498617
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors.
Rewinkel JB; Lucas H; Smit MJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
Bioorg Med Chem Lett; 1999 Oct; 9(19):2837-42. PubMed ID: 10522702
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitors.
Smolnikar I; Perdih A; Stegnar M; Prezelj A; Solmajer T; Urleb U; Obreza A
Pharmazie; 2007 Apr; 62(4):243-54. PubMed ID: 17484277
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
[TBL] [Abstract][Full Text] [Related]
6. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
[TBL] [Abstract][Full Text] [Related]
7. Thrombin inhibitor design.
Sanderson PE; Naylor-Olsen AM
Curr Med Chem; 1998 Aug; 5(4):289-304. PubMed ID: 9668196
[TBL] [Abstract][Full Text] [Related]
8. [A new generation of anticoagulants: design, synthesis and pharmacologic profile of thrombin inhibtors].
Schmid G; Ackermann J; Banner D; Gast A; Gubernator K; Hadváry P; Hilpert K; Labler L; Tschopp T
J Pharm Belg; 1995; 50(2-3):188-93. PubMed ID: 7674118
[No Abstract] [Full Text] [Related]
9. Interactions of thrombin with benzamidine-based inhibitors.
Stürzebecher J; Vieweg H; Wikström P; Turk D; Bode W
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):491-6. PubMed ID: 1515080
[TBL] [Abstract][Full Text] [Related]
10. A strategy for a rational approach to designing synthetic selective inhibitors.
Hijikata-Okunomiya A; Okamoto S
Semin Thromb Hemost; 1992 Jan; 18(1):135-49. PubMed ID: 1574714
[No Abstract] [Full Text] [Related]
11. 1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors.
Rewinkel JB; Lucas H; van Galen PJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
Bioorg Med Chem Lett; 1999 Mar; 9(5):685-90. PubMed ID: 10201829
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
